Strategies for Prevention and Repair of Vascular Permeability

Friday, February 27, 2015 - 2:00pm
Fung Auditorium, Powell-Focht Bioengineering Hall
Joe G. N. "Skip" Garcia

Senior V.P. for Health Sciences
University of Arizona

Strategies for Prevention and Repair of Vascular Permeability

Abstract: 
1. The participant will increase their awareness of health disparities in ALI and ARDS 2. The participant will understand at a greater level the genetics and genomics of susceptibility to ALI and ARDS 3. The participant will become more aware of new advances of therapies of ALI and ARDS
Bio: 

Joe G. N. "Skip" Garcia, MD, is the senior vice president for health sciences at the University of Arizona and interim dean of the UA College of Medicine – Tucson, an endowed UA professor of medicine and an elected member of the Institute of Medicine of the National Academies. An internationally noted physician-scientist, health administrator, scholar and educator, Dr. Garcia also is a leading authority on the genetic basis of lung disease and the prevention and treatment of inflammatory lung injury. A key member of the UA’s senior executive team, Dr. Garcia provides academic leadership for the colleges of the Arizona Health Sciences Center (AHSC): the UA College of Medicine – Tucson, the UA College of Medicine – Phoenix, the UA College of Pharmacy, the UA College of Nursing and the UA Mel and Enid Zuckerman College of Public Health. He also has direct leadership oversight of the UA Cancer Center.

Before joining the UA, Dr. Garcia served as vice president for health affairs at the University of Illinois and as the Earl M. Bane Professor of Medicine, Pharmacology and Bioengineering at the University of Illinois at Chicago. As vice president for health affairs, Dr. Garcia oversaw the University of Illinois Hospital & Health Sciences System (UI Health), a $1.2 billion health sciences and clinical enterprise. He also provided oversight of the University of Illinois Hospital and the University's federally qualified community health centers.

His prior leadership positions include director of the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University (1998-2005), chairman of the Department of Medicine at the University of Chicago (2005-2009), and vice chancellor for research at UIC (2010-2012).

Dr. Garcia is internationally recognized for his genetic-based research on lung disease and for development of novel therapies for critically ill patients with acute inflammatory lung disease. He has nearly 400 peer-reviewed publications. He has an expansive portfolio of NIH-sponsored research and continues to direct large federally funded programs.